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Abstract 
This systematic review investigated thirteen primary and secondary research studies from the 
past 20 years to determine the effects of intermittent fasting on chronic disease in adults 
through evaluation of biological markers pertaining to inflammation, oxidative stress, and the 
cardiovascular system. The dependent variables examined included heart rate, blood 
pressure, and cholesterol levels for cardiovascular risk; leptin and TNF- for inflammatory 
risk; and F2-Isoprostanes and free radicals for oxidative stress biomarkers. The reviewed 
studies found that there was a decrease in resting heart rate, systolic and diastolic blood 
pressure, blood LDL and total cholesterol levels, inflammatory cells, like leptin, TNF-, and 
insulin, and oxidative stress (isoprostanes and free radicals); and an increase in HDL 
cholesterol levels and insulin sensitivity in human and animal subjects engaged in various 
forms of intermittent fasting. The reviewed effects in both human and animal trials point to 
beneficial health effects of intermittent fasting in preventing and resisting chronic disease 
risk factors. In the short-term, it can be implicated that intermittent fasting could be 
successful in preventing chronic disease from a holistic perspective. This review is limited 
due to its narrow examination of only thirteen studies, minimal intervention time, and small 
population size for tested subjects.  
 
Keywords: intermittent fasting, intermittent energy restriction, caloric restriction, chronic 
disease, inflammation, oxidative stress, cardiovascular system 
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The Effects of Intermittent Fasting on Chronic Disease in Adults:  
A Systematic Review  
 Chronic diseases combined, which is a general term for any disease that lasts for three 
or more months and is generally incurable and ongoing, were recently labeled as a leading 
cause of death in the United States (Buttorff, Ruder, and Bauman, 2017). These detrimental 
diseases included diabetes, cardiovascular disease, hypertension, stroke, metabolic diseases, 
pulmonary conditions, and even cancer (Roberts and Barnard, 2005). Since chronic disease is 
a wide-encompassing term for a multitude of diseases, it is important to categorize them into 
objective categories. Chronic inflammation, oxidative stress, and cardiovascular disease were 
chosen as subheadings that were considered origins of chronic diseases.  
According to the Center for Chronic Disease Control (Buttorff, Ruder, and Bauman, 
2017), 60% of the 247.5 million adults living in the United States were inflicted with a 
chronic disease. Statistically, this led to a staggering 7 out of 10 Americans dying from issues 
complicated by a chronic disease. Within healthcare, $1.65 trillion was spent annually 
treating patients with one or more chronic diseases, which accounted for more than 75% of 
the $2.2 trillion that the U.S. spent on health care (Erdam, Prada, and Haffam, 2013). Even 
with these astonishing statistics, chronic disease is a preventable epidemic that some say is 
being neglected. According to (Horton, 2005): 
“The reduction of chronic disease is not a Millennium Development Goal (MDG). 
While the political fashions have embraced some diseases—HIV/AIDS, malaria, and 
tuberculosis, in particular—many other common conditions remain marginal to the 
mainstream of global action on health. Chronic diseases are among these neglected 
conditions.” (p.1514) 
INTERMITTENT FASTING EFFECTS ON CHRONIC DISEASE 
 
6 
Statistically, chronic diseases are hurting the financial status of the US healthcare system and 
leaving Americans with a 70% chance of dying from complications.  
Implementing an intervention plan to reduce the impact of chronic diseases could 
have multiple positive impacts on society. The keys to any intervention are prevention and 
reduction of any negative health consequences (Partnership to Fight Chronic Disease, 2007). 
Risk of chronic diseases may be reduced by lifestyle modifications and early detection. The 
CDC reported that the leading determinants of chronic disease risk derived from a lack of 
exercise, poor nutrition, and tobacco/alcohol use, all of which are relatively modifiable 
(“Power of Prevention,” 2009). Thus, regulations of modifiable risk factors have been 
identified as key in chronic disease prevention strategies (CDC, 2009).  
The most common approaches to modifying chronic disease risk factors involve 
instruction to stop the causes at the source such as: reduce or abstain from alcohol 
consumption, cease tobacco products, monitor caloric consumption with an eye toward 
energy balance (Willett et al. 2006). Success at adopting these lifestyle interventions has 
been limited (Abramson, 2005). Abramson (2005) stated that people failed in their exercise 
and diet protocol because of their lack of understanding of the different niches of fitness and 
nutrition such as the financial and time commitments of gym memberships, nutritional plans, 
meticulous cooking, and shopping for healthy foods (Roa, et al, 2013).  
For instance, many dieting fads have a start and end date; however, when considering 
chronic diseases prevention, modifying risk factors has been shown to require less acute 
approaches (Willett et al., 2006). Investigating attainable and sustainable lifestyle 
interventions shown to have positive effects on the reduction of chronic disease is an 
important and necessary endeavor (Abramson, 2005).  
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Adopting a healthy diet, in conjunction with regular physical activity, has been shown 
to improve health in humans (Coe, 2012). Feig and Lowe (2017) found that dietary 
consistency and compliance was key to maintaining weight and remaining healthy. Lemstra 
(2016) reported that finding a dietary plan that was easily adoptable and consistently 
followed was a challenge. 
Though consistency was identified as a challenge, Wegman and colleagues (2015) 
found that an alternate-day fasting protocol was easily followed and dietary compliance was 
only an issue when subjects were told to overeat. Intermittent fasting has been readily 
adopted over the last ten years (Collier, 2013). Intermittent fasting has been shown to be 
realistic, attainable, and sustainable solution to prevent modifiable risks of chronic diseases 
(Lay, 2014). Varady and Hellerstein (2007) found that intermittent fasting not only helped 
adults lose weight, but also helped decrease chronic disease risk through a myriad of 
secondary health benefits. 
Intermittent Fasting 
In the past decade, interest in new popular dieting fads have steadily led the general 
public toward intermittent fasting (Collier, 2013). (Research has shown intermittent fasting 
works to reduce overall body mass and body fat percentage in overweight and obese adults, 
as well as a way to maintain full-body health in active, nonobese adults, according to 
Ganesan, Habboush, and Sultan (2018)). Intermittent fasting is an umbrella term for short-
term caloric restriction for periods shorter than 24 hours, which leaves room for different 
protocols for participating in an intermittent fasting regimen (Patterson et al., 2015). There 
are three main regimens of intermittent fasting for health benefits: complete alternate-day 
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fasting (ADF), modified weekly fasting regimens (MIF), and time-restricted feeding (TRF; 
Patterson et al., 2015).  
Complete alternate-day fasting involves one day of zero caloric intake or energy-
producing ingestion followed by another day of feeding ad libitum, or as willed (Varady & 
Hellerstein, 2007). Modified weekly fasting regimens involve the popular 5:2 diet, which 
involves caloric restriction by consuming only 20-25% of needed energy calories for two 
consecutive days and then eating ad libitum for the other five days of the week (Patterson et 
al., 2015). Finally, time-restricted feeding involves a lack of energy consumption for a 
majority of each day (Patterson et al., 2015). For example, the 16:8 or 18:6 time-restricted 
feeding protocol would involve neither eating nor consuming calories for 16-18 hours and 
then eating ad libitum for 6-8 hours of the day. 
According to Collier (2013), intermittent fasting is an anomaly when it comes to most 
dietary plans because of its simple and straightforward constraints. Intermittent fasting plans 
allow participants to consume the types of foods they like, unlike most diet plans. The only 
difference between intermittent fasting and other diet plans is that participants are only 
allowed to eat for a few select hours of the day or on select days of the week, while most diet 
plans ask for the user to eat small meals all the time, reduce calorie intake, or eat special 
meals.  
  Intermittent fasting works by decreasing the overall caloric consumption period in 
one’s week, or by restricting the time an individual is allowing themselves to eat. By 
reducing the consumption period, the non-consumption time is also increased. By reducing 
the eating time, an individual reduces his or her caloric intake measured in kilocalories or 
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calories consumed by an individual in a defined amount of time, measured in calories 
consumed per day (Varady, Bhutani, Church, and Klemptel, 2009). 
The majority of health benefits accrued from intermittent fasting originate from the 
fasting period, which permits the body to predominately use stored fatty acids instead of 
macronutrients the user is consuming (Byrne, Sainsbury, King, Hills, Wood, 2018). Not only 
has this been shown to decrease excess body fat, but because fat is more difficult for the body 
to consume than carbohydrates, the body burns more calories by consuming stored fat 
(Hayward et al., 2014), This short-interval fat utilization method has had a significant impact 
on weight loss and favorable body composition changes (Ganesan, Habboush, and Sultan, 
2018). Increased stored fat utilization and weight loss aid are not the only benefits 
intermittent fasting has been shown to produce. Intermittent fasting has been found to have 
positive effects on inflammatory biomarkers, improved cardiovascular system efficiency, 
increased insulin sensitivity, reduction in oxidative stress levels, as well as improvement in 
the neurological system, the immune system and the lifespan (Collier, 2013).  
Biomarkers. 
Strimbu and Tavel (2010) defined a biomarker broadly as a biological sign, an 
objective indication of a medical state that can be measured accurately and quantified from 
outside of the patient. In terms of this review, biomarkers for inflammation included insulin, 
leptin and TNF- (Tumor Necrosis Factor Alpha); F2-Isoprostanes and free radicals for the 
investigation of oxidative stress; and resting heart rate, blood pressure, and cholesterol blood 
levels for cardiovascular measures (Collier, 2013). 
It is important to note that the effects of biomarkers have not been researched heavily 
in humans. Mayeux (2004) stated that the reason for this lack of human research was related 
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to the invasiveness of biomarker-testing in humans, causing ethical limitations to the studies. 
Even though there is lack of research in this area, intermittent fasting has been used as a way 
to reduce possibly harmful secondary biomarkers and improve beneficial secondary 
biomarkers (Aly, 2014). 
Intermittent fasting and oxidative stress. Oxidative stress, cellular inflammation, 
and insufficient cardiac activity are additional factors identified to lead to chronic disease 
(Khansari, Shakiba, and Mahmoudi, 2009). Roberts and Barnard (2005) found intermittent 
fasting helped decrease oxidative stress and cellular inflammation, as well as improve the 
health of the cardiovascular system. Oxidative stress derives from an imbalance in the ratio 
between the input into chemically reactive oxygen-containing chemical species and the 
output of these species by detoxifying and damage repairing tools, which occurs through the 
antioxidant defense system (Burton and Jauniaux, 2011). Oxidative stress is suspected to be 
linked to the development of neurodegenerative diseases, cardiovascular diseases, and even 
cancer (Khansari, Shakiba, and Mahmoudi, 2009). 
Free radicals. Free radicals are molecules that have an unpaired valence electron that 
is unstable. Biologically, they result from metabolic processes and are regulated by the 
antioxidant mechanisms. In excess, they can be harmful to the body and can cause various 
diseases, including Parkinson’s disease, Schizophrenia, and Alzheimer’s (Collier, 2013). Free 
radicals are not just dangerous by themselves, but can form other dangerous compounds, 
isoprostanes (Milne, Yin, Hardy, Davies, and Roberts, 2011). 
Isoprostanes are compounds formed in vivo from a reaction with free radicals. High 
levels of isoprostanes are suspected to increase risk of myocardial infarction and have been 
used as biomarkers for oxidative stress in research subjects (Montuschi, Barnes, and Roberts, 
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2004). Free radicals have been found to be detrimental by increasing the risk of 
neurodegenerative diseases and the risk of heart attacks (Montuschi, Barnes, and Roberts, 
2004). Collier (2013) reported that even though free radical studies remain minimal, evidence 
points to a reduction in free radicals throughout the body after a short-term bout of 
intermittent fasting protocol. 
Intermittent fasting and inflammation. Inflammation is a natural, biological 
response to harmful stimuli and serves as the body’s protective reaction to damaged cells or 
irritants (Johnson, Summer and Cutler, 2006). While beneficial in acute injuries, chronic 
inflammation has been found to lead to a number of life-altering diseases, including cancer, 
cardiovascular disease, neurodegenerative diseases, respiratory diseases, etc. (Kunnumakkara 
et al, 2018). 
Biological markers of inflammation include TNF- and leptin, as well as insulin 
(Johnson, Summer and Cutler, 2006). Leptin is a naturally-occurring hormone produced by 
adipose cells to help regulate energy balance in the body by inhibiting hunger. Leptin has 
also been found to be involved in the regulation of the inflammatory response. Chronically 
increased levels of leptin have been found to be associated with inflammatory-related 
diseases (Mattson and Wan, 2015). TNF- (Tumor Necrosis Factor) is a cell-signaling 
protein, activated by white blood cells called macrophages, that is involved in inflammation 
in the body. While beneficial in acute inflammation, TNF- also plays a part in many 
autoimmune disorders found to be related to chronic inflammation (Shojaie, Ghanbari, 
Shojaie, 2017). Both leptin and TNF- have been used as biological markers of chronic 
diseases and can be used to track the onset of a possible inflammatory-based chronic disease 
(Shojaie, Ghanbari, Shojaie, 2017). 
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Insulin resistance has been shown to cause an increase in chronic inflammation at a 
cellular level (Khansari, Shakiba, and Mahmoudi, 2009). Insulin, a hormone naturally-
occurring in the body, is secreted by beta cells, found in the pancreas, in order to regulate the 
metabolism of carbohydrates, fats, and proteins by increasing the use of carbohydrates as 
energy (McArdle, Katch, and Katch, 2015). 
         Diabetes Mellitus Type 2, commonly referred to as Type 2 Diabetes, is a metabolic 
disorder that involves the body’s increased insulin resistance, according to Kharroubi and 
Darwish (2015). Type 2 diabetes has been found to result from an increase of insulin 
resistance, which can be caused by obesity, lack of exercise, and genetic risks (Kharroubi and 
Darwish, 2015). Obesity and a lack of exercise can increase the risk of developing type 2 
diabetes, and certain genes can cause an increased risk of developing type 2 diabetes as well 
(Kharroubi and Darwish, 2015). In most cases, Type 2 diabetes can be managed by lowering 
cardiovascular risk factors, losing weight, exercising, and maintaining normal blood glucose 
levels (Mitchell, Catenaci, Wyatt, and Hill, 2011).  
 Insulin sensitivity, TNF-, and leptin have been investigated in relation to 
intermittent fasting (Sutton et al., 2018). Because of intermittent fasting’s proposed chronic 
anti-inflammatory effects, there is evidence that intermittent fasting may lead to a decrease in 
these inflammatory biomarkers, therefore improving chronic cellular inflammation chronic 
diseases (Shojaie, Ghanbari, and Shojaie, 2017). 
Intermittent fasting and the cardiovascular system. The cardiovascular system, 
comprised of the heart, blood vessels, and its contained blood, is the organ system of the 
body that allows blood to circulate and transport nutrients, hormones, and blood cells 
carrying oxygen and carbon dioxide. Cardiovascular system variables include resting blood 
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pressure and heart rate, as well as total cholesterol levels (Varady, Bhutani, Church, and 
Klemptel, 2009). Heart rate is measured in beats of the heart per minute (McArdle, Katch, 
and Katch, 2015). Blood pressure is the pressure of circulating blood on the walls of arterial 
and venous blood vessels (McArdle, Katch, and Katch, 2015). It is measured in millimeters 
of mercury above the surrounding atmospheric pressure and is comprised of systolic and 
diastolic blood pressure. Systolic blood pressure is the maximum pressure during one 
heartbeat, while diastolic blood pressure is the minimum pressure between two heart beats. A 
normal resting blood pressure is usually a 120 mmHg systolic pressure over a 80 mmHg 
diastolic pressure (McArdle, Katch, and Katch, 2015). A heightened blood pressure and heart 
rate suggest a heart that is working harder than it needs to because of an underlying issue, 
according to McArdle, Katch, and Katch (2015). 
In addition to the concerns raised with an unhealthy blood pressure and heart rate, 
cholesterol, a fatty substance that is found in the blood, can also be problematic if levels rise. 
Cholesterol is an organic molecule characterized by a waxy-like texture that is found 
naturally in the body (Varaday, Bhutani, Church, and Klempel, 2009). It is vital to the body 
to make and maintain membranes in the body; however, excess amounts of cholesterol can 
lead to heart attacks, stroke, or various vascular diseases (Varaday et al., 2009). Low-density 
lipoproteins (LDL) and high-density lipoproteins (HDL) are two common biomarkers found 
in health studies. LDL is sometimes referred to as the “bad type” of cholesterol because an 
increased level of LDL can lead to a buildup of cholesterol in arterial walls, leading to heart 
attacks and stroke (Varaday et al., 2009).  
Heightened heart rate, blood pressure, and cholesterol levels generally means there is 
something wrong going on in the body. In order to combat these issues, health professionals 
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recommend exercise and special dieting plans when encountering these issues in patients, 
according to the American Heart Association. Although these instructions are helpful and 
have been proven to aid in cholesterol levels, resting heart rate, and blood pressure levels, 
there are hypotheses about whether or not intermittent fasting could play a major role in 
helping reduce these cardiovascular biological markers even without the aid of exercise 
(Francis, Young, and Lara, 2017).  
Purpose 
         The purpose of this review was to explore the biological effects of intermittent fasting 
in human adults, beside the effect on weight, that can lead to chronic disease. This systematic 
review also worked to explore the effects of intermittent fasting on chronic disease 
biomarkers in patients who already had been previously diagnosed. This systematic review 
synthesizes completed research on intermittent fasting, effects on the cardiovascular system 
(heart rate, blood pressure, cholesterol levels), inflammation (leptin and TNF-), and 
oxidative stress biomarkers (f2-isoprostanes and free radicals). While intermittent fasting is 
theorized to cause weight loss by a combination of reduced caloric intake and burning of 
stored body fat, it has led to benefits like an increase in insulin and leptin sensitivity, as well 
as a decrease in cholesterol levels, inflammation, free radicals, and resting blood pressure and 
heart rate. 
         This review evaluated the clinical evidence that fasting is beneficial in humans. 
Clinical evidence has involved randomized controlled trials of the effects of fasting on 
relevant surrogate outcomes (e.g. cholesterol, inflammatory biomarkers, etc.) as well as the 
actual clinical endpoints (e.g. diabetes, cardiovascular disease, etc.) and any other studies of 
other supporting clinical outcomes. In addition, this study will include and discuss results 
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taken from animal studies to use as supporting evidence; however, no conclusive remarks 
will be made based on them. 
Methods 
 The review of participating studies followed a systematic procedure, which included 
particular inclusion criteria during searches and data extraction. The primary aim of these 
searches were to 1) identify randomized clinical trials of intermittent fasting in which a 
standard diet or control group was used, 2) find studies that tested for the listed biomarkers in 
humans, and 3) find studies that observed the desired clinical endpoints in humans. Searches 
were also used to analyze animal studies meeting this criteria, in areas with little research. 
Inclusion and Exclusion Criteria 
 Study designs included in this review were both human and animal clinical trials, 
with emphasis on use of human trials. These trials were randomized controlled trials and 
pilot studies. Original research studies and review articles were included, but case studies, 
surveys, and abstracts were excluded from review. To be included for this review, studies 
had to use human subjects of any age or BMI that would undergo an intermittent fasting or 
alternate-day feeding protocol. Studies researching Ramadan fasting were excluded because 
of their differing eating patterns from standard intermittent fasting protocols. Studies that did 
and did not include a control or comparable group were included to give a broader 
perspective of intermittent fasting research; however, studies with control groups were 
primarily used for data analysis. 
 No limit was placed on the duration of the intermittent fasting of subjects. Studies 
were excluded if participants were taking medication designed to induce weight loss or 
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reduce blood pressure, if participants were on a given diet (not ad libitum feeding), were 
diagnosed with cancer, were adolescent, elderly, or pregnant.  
 To be included for this systematic review, studies needed to measure one or more 
variables prior to the commencement of the intermittent fasting diet and following the 
cessation of the intermittent fasting period that the study investigated. Studies investigating 
parameters during the course of the intermittent fast program were favored.   
Search Strategy 
 A systematic review of the literature was conducted by searching computerized 
databases for scholarly, peer-reviewed articles that had been published between January 1998 
and December 2018, with limitations to the English language. Computerized data bases that 
were used included Bulldog One Search, found through the Gardner-Webb Library home 
page, Google Scholar, and PubMed/MEDLINE. Search engine requests included the terms, 
“Intermittent fasting”, “energy restriction,” and “caloric restriction,” when researching 
intermittent fasting studies; “Inflammation,” “oxidative stress,” and “cardiovascular system,” 
as well as their sub-terms: “blood pressure,” “heart rate,” “leptin,” “TNF-,” “Insulin,” 
“isoprostanes,” and “free radicals” were used to research the affected variables in studies. In 
addition, the reference list of articles found in the search articles were examined for other 
trials and studies to ensure that all relevant studies were found.  
 Multiple searches were conducted with variations of the searched phrases, which 
included one of the primary “intermittent fasting” phrases and at least one of the sub-terms 
listed above.  
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Data Analysis 
 The titles and abstracts of the studies identified through use of the search strategy 
were screened prior to data analysis to ensure that they met the inclusion criteria. The full 
texts of the approved relevant studies were retried and then screened again with a full read 
through, analyzing the inclusion and exclusion criteria. Studies discussed in the investigated 
research articles that were possibly relevant to this review were investigated and prepared 
according to this same system. If the studies did not abide by the inclusion/exclusion criteria, 
they were discarded.   
Results 
Search Results and Study Characteristics 
After a thorough search of the search engines, a total of 343 studies were found to be 
relevant towards the objectives of this review. Of these 343 studies, abstracts of these were 
read and analyzed. Thirteen were found fit, after reviewing inclusion and exclusion criteria, 
to be discussed in this review. A total of thirteen studies were included in this review, with 
eight of the studies pertaining to inflammatory biomarkers, three of the studies examining 
oxidative stress biomarkers, and eight of the studies examining cardiovascular chronic 
disease biomarkers. Of these 13 studies, seven of them used human subjects, while two of 
them used rats as subjects, and four were review studies looking at both human and animal 
trials. The intermittent fasting regimens varied across studies, with some including alternate 
day feeding (ADF), some modified weekly fasting (MIF), and some time-restricted feeding 
(TRF). Intermittent fasting regimen durations ranged from three weeks to twelve weeks. 
Study characteristics for studies with human subjects were identified and organized in Table 
1, while animal subject study characteristics were identified in Table 2.  
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Table 1. Study Characteristics of Intermittent Fasting Studies with Human Subjects 
Author/Year IF 
Protocol 
Study 
Duration 
(weeks) 
Number of 
Participants 
Studied 
variables 
Mean age 
per group 
(years) 
Mean 
weight per 
group (kg) 
Bhutani et 
al., 2013 
ADF 12 64 LDL, HDL, 
total 
cholesterol, 
HR, SBP, 
DBP, insulin 
45 93 
Harvie et 
al., 2011 
MIF (2:5) 26 107 Oxidative 
stress, leptin, 
TNF-, 
isoprostanes, 
HR, SBP, 
DBP, LDL, 
HDL, insulin 
sensitivity 
40 81.5 
Heilbronn et 
al., 2005 
ADF 3 16 BP, LDL, 
HDL, insulin 
sensitivity 
34, 32 59.7, 80.6 
Johnson et 
al., 2007 
ADCR 8 9 TNF-, LDL, 
HDL 
N/A 105 
Sutton et al., 
2018 
TRF 
(18:6) 
5 22 Oxidative 
stress, HR, 
BP, insulin 
sensitivity 
36 Not 
measured 
Varady et 
al., 2009 
ADF 12 30 HR, LDL, 
HDL, Total 
Cholesterol 
47 77, 77 
Wegman et 
al., 2015 
ADF 10 24 Oxidative 
stress, plasma 
Insulin 
24 Not 
measured 
Notes. IF- intermittent fasting, ADCR- alternate day caloric restriction, TNF-- Tumor 
Necrosis Factor , SBP- systolic blood pressure, DBP- diastolic blood pressure, kg- 
kilograms, HDL- High-density lipoprotein cholesterol, LDL- low-density lipoprotein 
cholesterol 
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Table 2. Study Characteristics of Intermittent Fasting Studies with Animal Subjects  
Author/Year IF 
Protocol 
Study 
Duration 
(weeks) 
Type/ 
number of 
animal 
subjects 
Studied 
variables 
Mean age 
(months) 
Mean 
weight 
(grams) 
Ahmet et 
al., 2005 
ADF 12 Sprague-
Dawley/ 
n=60 
HR, 
inflammation 
2 66 
Wan et al., 
2010 
ADF 12 Male 
Wistar/ 
n=30 
Inflammation, 
Insulin, BP 
2.5 460 
Notes. ADF- alternate day feeding, HR- heart rate, BP- blood pressure 
The review articles that were included in the review discussed studies that 
investigated the effects of intermittent fasting on chronic disease risk factors and the 
implications behind the results of these studies. Of the four review articles, none of them 
followed systematic review guidelines, but all four of them were found to withstand the 
inclusion criteria for this study. 
Study Outcomes 
 Each study was reviewed to clarify and confirm or deny implications of previous 
research on intermittent fasting affects risk factors for developing chronic disease in adults.  
 Study Outcomes of Human Trials. 
A controlled randomized trial study investigating the effects of an intermittent fasting 
diet and exercise on plasma lipids in obese humans was conducted by Bhutani, Klempel, 
Kroeger, Trepanowski, Varady (2013). The study examined 64 obese subjects that were 
randomly selected to one of four groups: combination of alternate day fasting (ADF) and 
endurance exercise, ADF only, exercise only, and control. ADF subjects were instructed to 
eat ad libitum every other day, followed by a fasting day of 25% of their normal daily caloric 
intake on a 3-day rotating menu plan provided. After 12-weeks of following the dieting 
protocol, total cholesterol and LDL cholesterol was reduced in the ADF and combination 
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intervention groups (12 ± 5%, P < 0.05), while HDL cholesterol increased (18 ± 9%, P < 
0.05). These findings concluded that the combination of intermittent fasting and endurance 
exercise produce superior changes in lipid indicators of heart disease risk.  
Heilbronn et al. (2005) investigated the effects of a short-term intermittent fasting 
dieting regimen on body weight and biomarkers of longevity in nonobese subjects. Sixteen 
healthy subjects were recruited and instructed to fast intermittently for three weeks with one 
day eating ad libitum, followed by a day of a complete fast, following a strict alternate-day 
feeding protocol (ADFP). A fasting blood sample and blood pressure were taken at baseline, 
throughout, and after the cessation of the dieting period. Results showed a decrease in fasting 
insulin of 57 ± 4% (P < 0.001) and insulin was reduced after fasting days, suggesting an 
improved insulin sensitivity; however, fasting insulin did not drastically decrease following a 
12-hour fast. In addition, systolic and diastolic blood pressure were not significantly reduced 
by the intermittent fasting intervention. It was noted that this study’s design may have 
affected results because of a lack of dietary adherence from subjects. It was concluded that 
the intermittent fasting protocol did slightly increase insulin sensitivity, which could help 
improve benefits of chronic disease; however, these results were inconclusive. 
 In addition, Johnson et al. (2006) conducted an eight-week study to investigate the 
effects of ADCR on markers of oxidative stress and inflammation in overweight adults with 
moderate asthma. The subjects (n=10) were instructed to eat ad libitum (at one’s desire) for 
one day, followed by a day of consuming less than 20% of their normal caloric intake. Blood 
was collected throughout the study in order to measure markers of oxidative stress and 
inflammation. Results indicated a reduction of all levels of leptin, serum cholesterol, TNF-, 
and markers of oxidative stress (isoprostanes). The improved clinical findings demonstrated 
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rapid and beneficial effects of an intermittent fasting protocol, suggesting a new approach for 
therapeutic intervention for those with asthma.  
 With a discussion about the effects of intermittent fasting on all three of the chronic 
disease risk factors reviewed, Sutton et al. (2018) presented a study that investigated the 
effects of time-restricted feeding (TRF) on insulin sensitivity, blood pressure, and oxidative 
stress in men with Prediabetes. In this study, 22 men were separated into two groups, a time 
restricted feeding protocol group, eating for six hours and fasting for 18 hours of each day, 
and a control group, that ate and fasted for 12 hours each day. The subjects remained on this 
diet regimen for five weeks before they changed diet protocols. Throughout and after 
cessation of the study, blood samples and blood pressure were taken for each subject. They 
found that subjects following the TRF protocol had an increased insulin sensitivity as well as 
decreased blood pressure and oxidative stress levels. It was concluded that, because of the 
results being independent of weight loss, intermittent fasting could improve aspects of 
cardiometabolic health. 
In addition to the findings on chronic disease risk markers, a study by Harvie et al. 
(2010) researched the effects of both an intermittent and continuous energy restriction 
protocol on weight loss and chronic disease risk biomarkers in young overweight women. 
107 subjects with an average age of 40 were separated into two different groups: an 
intermittent energy restriction and continuous energy restriction group. The intermittent 
fasting group followed two days of eating 75% of their normal daily caloric intake, followed 
by five days of eating according to a nutrient composition Mediterranean-type diet. The 
continuous energy restriction group followed the Mediterranean-type diet for seven days of 
the week. The study lasted 6 months (26 weeks) and blood samples were taken at the end of 
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the first, third, and sixth month of the diet. Results showed similar weight loss in both 
groups, a modest decrease in fasting insulin in both groups, however, improvements in 
insulin sensitivity were greater in the intermittent fasting group. Both groups showed a 
modest reduction in oxidative stress biomarkers, inflammatory biomarker Leptin, LDL 
cholesterol, total cholesterol, and systolic blood pressure. Limitations were listed as the 
short-term length of the study and the lack of inclusion of local changes, like food 
substitutions or environmental/stress changes, that could have occurred.  
 Varady et al. (2009) investigated the effects of short-term modified alternate day 
fasting (ADF) on weight loss and cardioprotection. Sixteen obese subjects (twelve women 
and four men) completed a 10-week ADF protocol, which followed a two-week control 
phase, four-week ADF controlled phase, and four-week self-selected ADF phase. Blood 
samples were taken after a 12-hour fasting at the end of each phase. As a product of the 10-
week study, dietary adherence remained relatively high (86%), resulting in a decrease of 
mean body weight of subjects (5.6 ± 1.1%), total cholesterol (21 ± 4%) and LDL 
cholesterol levels (25 ± 10%), and systolic blood pressure (from 124 ± 5 to 116 ±
3 mm Hg). Findings suggested that an ADF diet could help obese individuals reduce weight 
and decrease coronary artery disease risk.  
A 10-week double crossover study, completed by Wegman et al. (2015), investigated 
the effects of an intermittent fasting regimen on oxidative stress and gene expressions. This 
study completed a 10-week long regimen of alternate day caloric restriction (ADCR), in 
which subjects alternated a day of eating 175% of normal daily caloric intake, followed the 
next day by 25% of their normal daily caloric intake. The subjects were told to report their 
level of comfort and adherence to the diet throughout. This study found that when subjects 
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strictly adhered to the intermittent fasting protocol, there was no change of oxidative stress 
markers, and there was a decreased level of plasma insulin levels. This study suggests that an 
intermittent fasting dieting paradigm is acceptable in healthy individuals, but further research 
would need to be conducted to further assess risks and benefits. 
Of these previously stated scholarly articles, the resulting effects of intermittently 
fasting groups are listed in Table 3 and sectioned between their effects of each chronic 
disease risk factor.  
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Table 3. Effects of Intermittent Fasting on Chronic Disease Risk Factors in Human Studies 
Study Cardiovascular 
Effects 
Oxidative Stress 
Effects 
Inflammatory 
Effects 
Bhutani et al., 
2013 
LDL:  (-12 ± 5%) 
HDL:  (18 ± 9%) 
Total Cholesterol: 
unchanged 
HR: unchanged  
SBP:  (-3 ± 1%) 
DBP:  (-2 ± 2%) 
Not measured Insulin:   
(-21 ± 15%) 
Harvie et al.,  
2011 
LDL:  (-9.7 %) 
HDL: unchanged 
SBP:  (-3.7 mm Hg) 
DBP:  (-4.3 mm Hg) 
Oxidative Stress:  
 
Leptin:  (-40.1%) 
TNF-:  (-2.1%) 
Insulin:  
(-2.1 U/mL) 
Heilbronn et al., 
2005 
BP: unchanged 
LDL:  
HDL:  
Not measured Insulin sensitivity:  
Johnson et al., 
2007 
LDL:   
(-10.5 ± 8.9%) 
HDL:  (4.1 ± 1.3%) 
Not measured  TNF-:  
Sutton et al., 
2018 
HR:  
BP:  
Oxidative Stress:  Insulin sensitivity:  
Varady et al., 
2009 
LDL:  
(26.0 ± 8.2%) 
HDL: Unchanged 
Total Cholesterol:   
(-18.0 ± 4.3%) 
SBP: 
(4.4 ± 1.8%) 
HR:  
Not measured Not measured 
Wegman et al., 
2015 
Not measured Oxidative Stress: 
Unchanged 
Plasma Insulin:   
(-1.01 U/mL) 
Notes. IF- Intermittent fasting, SBP- systolic blood pressure, HR- heart rate 
 
Study Outcomes of Animal Trials 
 In a 12-week study, Ahmet, Wan, Mattson, Lakatta, Talan (2005) investigated the 
effects of an intermittent fasting diet on two-month-old rats. The intermittent fasting protocol 
included an alternate-day feeding intermittent fasting protocol with a standard rat diet ad 
libitum on eating days. After three months of dieting, an electrocardiogram (EKG) was 
conducted prior to and post a coronary artery ligation, causing a myocardial infarction. The 
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study found that 24-hours after the induced MI, rats in the intermittent fasting group had a 
significantly reduced MI, inflammatory response, and apoptotic myocytes when compared to 
the control group. An electrocardiography was performed on surviving rats 10 weeks after 
the induced MI, with a continued intermittent fasting regimen, and found that there was less 
left ventricular remodeling, better left ventricular function, and no MI expansion in the 
intermittent fasting group compared to the control group of rats. It concluded that intermittent 
fasting could protect the heart from ischemic injury and aids in anti-inflammatory 
mechanisms.  
 In addition, Wan et al. (2010) conducted another study, which looked at the cardio 
protective effects of intermittent fasting in rats after an induced MI and stroke. This study 
utilized 30 two-and-a-half month-old male Wistar rats that were maintained for one month 
prior to initiation of dietary protocol. The rats were separated into either an ad libitum or 
intermittent fasting diet, following a 12-week protocol. At the beginning, during, and near the 
end of the study, blood samples were taken. At the end of the 12 weeks, the rats had a 
myocardial infarction induced by a coronary artery ligation surgery. Following the ligation, 
permanent ligation of the coronary artery and markers of inflammation were significantly 
smaller in rats following the intermittent fasting diet protocol. In addition, insulin levels were 
significantly lower in the rats following the intermittent fasting diet than the ones following 
the ad libitum diet. It concluded that these results suggest an intermittently fasted diet could 
improve cardiovascular health and cardio protective elements compared to an ad libitum diet. 
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Table 4. Effects of Intermittent Fasting on Chronic Disease Risk Factors in Animal Studies 
Study Cardiovascular 
Effects 
Oxidative Stress 
Effects 
Inflammatory 
Effects 
Ahmet et al., 
2005 
HR:  Not measured Inflammation:  
 
 Wan et al., 2010 
HR:   Not measured Inflammation:   
(-18%)  
Plasma Insulin:  
Notes. IF- intermittent fasting 
 Study Outcomes of Review Articles 
In addition to the clinical findings of animal and human studies, four reviews were 
analyzed to understand the effects of intermittent fasting on chronic disease risk factors.  
 A review study by Mattson, Longo, and Harvie (2017) analyzed intermittent fasting 
studies to determine whether or not previous research verifies the efficacy of intermittent 
fasting in improving general health, and prevention and management of chronic diseases. 
Mattson found that with studies in animals, there were profound general health benefits for 
laboratory rats and mice. The studied articles showed animal subjects improving functional 
outcomes and counteracting disease processes, such as cardiovascular disease, diabetes, 
cancer, and some neurological disorders. In human trials, health benefits were just as 
beneficial. Human subjects completing a short-term intermittent fasting protocol were found 
to have improvements in many health indicators, including insulin sensitivity and reduction 
in risk factors for cardiovascular disease. 
 In a study by Varady and Hellerstein (2007) both human and animal studies were 
analyzed to determine if chronic disease prevention is possible from following a caloric 
restricted or alternate-day fasting regimen. This review looked at 15 studies that investigated 
the health benefits of intermittent fasting. Consistently reduced insulin concentrations, 
reduced resting heart rate and blood pressure, and lowered LDL and total cholesterol levels 
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were all reported in rats following an alternate-day feeding protocol. In human trials, short-
term alternate-day feeding protocols resulted in inconsistent results for insulin sensitivity, 
blood pressure, and inflammatory effects; however, limitations to these research studies 
include a limited intervention period. It concluded that alternate-day fasting may effectively 
result in decreased risk factors of cardiovascular disease and increases of resistance to 
oxidative stress, which could result in a decreased risk of chronic disease. 
 In addition, another review performed by Mattson and Wan (2005) investigated the 
effects of intermittent fasting on the cardiovascular and cerebrovascular systems. Similarly, 
this review found evidence of decreased resting heart rate, blood pressure, insulin resistance, 
LDL and total cholesterol levels in addition to a reduction in circulating levels of TNF- in 
laboratory rats and mice. In reviewed human studies, there were similar results with obese or 
overweight subjects. A reduction in inflammation, oxidative stress, heart rate, blood pressure, 
and LDL and total cholesterol levels were all reported. However, the study stated that there 
was little research that investigated the same effects of intermittent fasting in humans with a 
healthy weight.  
 Lastly, a study conducted by Ganesan, Habboush, and Sultan (2018) examined the 
effects of intermittent fasting in four randomized controlled studies using adult, human 
subjects. This review looked at studies that investigated the effects of an alternate day fasting 
protocol on weight loss and other biomarkers. It was found that short-term use of alternate-
day fasting resulted in weight loss across the board as well as reductions in LDL, total 
cholesterol, and systolic blood pressure. The review also found a decrease in insulin 
resistance in two of the four studies. In regards to the review’s limitations, it concluded that 
this review was limited to English-speaking adults and obese individuals. Future research 
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should include evidence on how intermittent fasting could help improve biomarkers in 
healthy individuals. 
Discussion 
 After a systematic review of the 13 studies, the synthesis of the collected data 
determined that various intermittent fasting protocols were effective in reducing caloric 
intake and body weight. In addition, there was evidence supporting the idea that intermittent 
fasting could reduce chronic disease risk markers in human and animal subjects; however, 
there were other plausible reasons for the improvements of chronic disease risk markers.  
Main Findings 
 A systematic review of the 13 studies showed that intermittent fasting can play a role 
in decreasing chronic disease risk factors biomarkers. Yet, there was noticeable variability in 
the reviewed studies that needs to be taken into consideration. Of the nine reviewed studies 
with both animal and human subjects, the hypothesis was borne out by decreases in LDL 
concentrations, systolic blood pressure, diastolic blood pressure, heart rate, oxidative stress, 
TNF-, and insulin, and the hypothesis was borne out by increases in HDL concentrations 
and insulin sensitivity for majority of the human studies. These findings support the claim 
that intermittent fasting can help decrease risk factors for chronic disease.  
Human subjects who were previously diagnosed with a chronic disease showed more 
drastic improvements of chronic disease risk factors after completing a short-term 
intermittent fasting regimen than healthy human subjects. With that information, it can be 
implied that intermittent fasting regimens can be used to reduce risk factors of those who are 
already diagnosed. Even though it cannot be inferred that intermittent fasting regimens could 
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treat chronic diseases, statistical improvements of chronic disease risk factors are a step 
forward for these individuals.  
 After review of the general main findings, results and implications of each of the 
chronic disease risk factors are reviewed and stated below. 
 Oxidative stress. Among the studies investigating the impact of intermittent fasting 
on oxidative stress, there was supporting evidence that intermittent fasting could decrease 
oxidative stress in subjects. In studies run by Sutton et al. (2018) and Harvie et al. (2009), 
oxidative stress decreased following a five month and 26-month stent of alternate day fasting. 
The reviewed studies found that following an intermittent fasting diet could improve 
oxidative stress resistance and decrease oxidative stress because of the oxidative stress 
hypothesis and stress resistance hypothesis (Mattson and Wan, 2005). The oxidative stress 
hypothesis states that because intermittent fasting protocols cause a reduction in caloric 
intake, there is less means for the production of free radicals in the mitochondria of the cells. 
However, this implies that caloric restriction diets would cause the same effect on oxidative 
stress. On the other hand, the stress resistance hypothesis explains that because of the 
extended periods of fasting, which causes stress, the body is able to resist the stress of fasting 
better. This stress resistance can be associated with an increased cellular resistance to 
oxidative injury. It implied that because of this improved stress resistance from intermittently 
fasting and restricting caloric intake, the body becomes more immune to stressors and is 
therefore better prepared to combat chronic disease risk factors and possibly prolong life.  
In addition to these two hypotheses, another theory, called the induction of scarcity 
program hypothesis, explains the decrease in oxidative stress following an intermittent 
fasting protocol (Varady and Hellerstein, 2007). This hypothesis explains that when one 
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utilizes an energy restricting diet, cellular and metabolic programs react with the intermittent 
scarcity of energy consumption, causing a decrease in metabolic processes that contribute to 
the degradation of cells.  
While all three of these theories could explain the induced deficit of measured 
oxidative stress, evidence for these theories are minimal and only present in trials using 
rodents and cellular subjects, like yeast. A more extensive exploration of these effects from 
an intermittent fasting regimen could create improved insight on its effects. 
 Inflammation. 
 In both human and animal subjects, the reviewed articles found that inflammatory 
effects from following an intermittent fasting diet have the potential to be positive. Of the 
seven reviewed clinical trials with human subjects, six of the studies tested for inflammatory 
biomarkers, including plasma insulin, insulin sensitivity, and TNF-. A decrease in plasma 
insulin, leptin, TNF-, with an increase in insulin sensitivity was discovered in Sutton et al. 
(2018). These decreases in inflammation biomarkers in humans can be inferred to help 
prevent and combat inflammation found in chronic diseases, like diabetes, cardiovascular 
disease, chronic neurodegenerative diseases, and autoimmune diseases.  
The decrease in plasma insulin and the improvement in insulin sensitivity, prevalent 
in six of the seven human trials, has been shown to cause a reduction in Type-2 diabetes risk 
(Varady and Hellerstein, 2007). The reasoning for this correlation is based on the increase of 
fat oxidation during fasting periods of an intermittent fasting protocol, which causes a 
reduction of intracellular lipid accumulation. For individuals struggling with Prediabetes or 
diagnosed Type-2 diabetes, intermittent fasting could be a possible health-improving 
implementation. To add on, leptin, which has been found to lead to insulin resistance and 
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even breast cancer risk, was also reduced during the one reporting human study (Harvie et 
al., 2011). This decrease, as stated by Harvie et al. (2011), could have aided in the decrease 
of plasma insulin and increase in insulin sensitivity, therefore improving the inflammatory 
response.  
In addition, a decrease in TNF- found in the reviewed human trials point to a 
decreased risk of inflammation-based chronic diseases. The two human trials reporting TNF-
 concentrations discussed that because of TNF-’s previous correlation to suppression of 
inflammation, a reduction of TNF- could improve asthmatic symptoms and inflammatory 
risk factors found in cardiovascular disease, rheumatoid arthritis, and autoimmune diseases 
(Johnson et al., 2007). Again, this evidence supports intermittent fasting as a potential health 
implementation for reducing the risk of inflammation-based chronic diseases. 
Furthermore, animal studies showed a reduced inflammatory response to cardiac 
injury by artificial ligation. Ahmet et al. (2005) and Wan et al. (2010) showed a decrease in 
inflammatory cells within the hearts of surviving rodents 24-hours after a medically-induced 
ischemic stroke, following six weeks of an alternate day fasting protocol. This evidence 
suggests that an intermittent fasting diet could help promote cardioprotective effects even 
prior to a cardiovascular injury. These results can translate to inflammatory-based chronic 
diseases, as well.  
 Examined review articles point to a decrease in inflammation after a short regimen of 
intermittent fasting, causing a decreased risk of cardiovascular disease, a decreased risk of 
diabetes, and possibly a decrease in certain cancer risks. These results point to an effective 
improvement of chronic disease risk factors in animals and humans; however, human studies 
have been equivocal in their determination of direct causation. Because of a lack of objective, 
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thorough evidence, results pointing toward a reduction in chronic inflammatory diseases 
cannot be conclusive in human subjects.  
 Cardiovascular system. 
 The main findings affecting the cardiovascular system include a lowered heart rate, 
systolic and diastolic blood pressure, and LDL cholesterol concentration. HDL cholesterol 
concentrations were found to be raised after a bout of intermittent fasting, while total 
cholesterol levels were found to decrease or remain the same in human subjects.  
 The cardiovascular effects were analyzed in the four reviews investigated. These 
cardiovascular effects include the increase of HDL cholesterol and the reduction of resting 
heart rate, blood pressure, LDL cholesterol, and total cholesterol concentrations. The 
reductions of resting heart rate and blood pressure were found to be significant in animal 
trials. It was found that within animal studies, cardiovascular systems of rats and mice 
responded to an intermittent fasting treatment similar to the way it responds to aerobic 
exercise (Mattson, Longo, Harvie, 2017). The relationship between intermittent fasting and 
its effects similar to those of aerobic-exercise seems compelling enough to state that because 
of the induced stress of caloric restriction, there is an improvement of health markers. 
Resting heart rate and blood pressure reduced significantly within the first few weeks 
of intermittent fasting and then remain reduced while following an alternate-day feeding 
protocol. However, these reductions only remained temporarily after the cessation of an 
intermittent fasting diet, proving that cardiovascular benefits are not sustained much after the 
end of an intermittent fasting period. So, it implies that intermittent fasting can be used to 
improve one’s aerobic baseline prior to the beginning of an aerobic exercise protocol. This 
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comparison has not been researched or evident in human trials, so it cannot be concluded that 
intermittent fasting could serve as a substitute for physical exercise early in human subjects. 
 Furthermore, total and LDL cholesterol concentrations following an intermittent 
fasting period were reduced in both human and animal trials. These reductions, more 
prominent in previously overweight or obese subjects, can correlate to the reduction in body 
mass and may not be direct effects from following an intermittent fasting diet. However, 
these reductions can be expected to decrease the risk of cardiovascular disease and stroke, 
whether it was from direct effects of the intermittent fasting diet or from the reduction in 
body mass. Studies following the effects in healthy individuals showed only modest 
improvements of cholesterol levels, showing that plasma cholesterol levels may not be a 
major consequence of intermittent fasting.  
With these results in mind, it can be concluded that following an intermittent fasting 
protocol can lead to a modest reduction in resting heart rate, blood pressure, and cholesterol 
concentrations in healthy, human subjects. These moderate effects improve the overall 
cardiovascular function and resilience in combatting ischemic injury, prevalent in stroke and 
heart attacks. It infers that because of these improved biological markers, intermittent fasting 
has the potential to be a legitimate procedure to follow in order to improve cardiovascular 
health in overweight or obese individuals prior to the beginning of an exercise protocol.  
In the future, while research on intermittent fasting points to the improvement of 
overall cardiovascular health, more extensive research needs to be expanded in order to 
understand the direct and indirect effects of intermittent fasting on cardiovascular health. 
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Limitations 
 While this study followed an extensive systematic procedure of review, there are 
limitations that exist. Because of intermittent fasting’s recent popularity, there are few studies 
that are conclusive on the health benefits of this dieting protocol. 
 In addition, the lack of longitudinal studies on intermittent fasting leaves one 
questioning the long term effects of the dieting protocol. While short-term intermittent 
fasting studies show an improvement in chronic disease risk markers, there could be negative 
effects of intermittent fasting in the long run, although these are not heavily researched. 
 Intermittent fasting studies showed improvements in chronic disease risk markers, yet 
these improvements were much more drastic in previously diagnosed chronic disease patients 
and obese or overweight subjects. Because of this, it infers that intermittent fasting does not 
directly cause these improvements in chronic disease risk factors, but is indirectly involved in 
the decrease of these biomarkers because of a decrease in body weight. Weight loss has been 
shown to improve overall health, which could cause the decrease in these investigated 
biomarkers. It is important to consider though that intermittent fasting does, in fact, lead to 
weight loss.  
 While this study thoroughly investigated the reviewed articles, there were only ten 
short-term clinical trials studied, which only used a limited number of participants. The 
number of human subjects ranged from nine to 107 subjects, with an average of 39 subjects 
per study. While this amount of participants is beneficial, it is hardly conclusive for the 
general population.  
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Implications 
 After assessment and consideration of the results from the reviewed studies, further 
testing of intermittent fasting is needed. While animal studies of intermittent fasting 
protocols show a clear, positive effect of intermittent fasting on cardiovascular biological 
markers, other chronic disease risk factors are not as clearly defined. Of the seven clinical 
studies with human subjects, only three of these studies discussed the oxidative stress effects 
from following a short-term bout of intermittent fasting. Within these studies, biological 
markers were used but were not thoroughly discussed and implications were minimal. 
Research discussing more in-depth analyses with broader implications is needed in order to 
establish the beneficial effects of intermittent fasting on the general population, for 
combatting chronic illnesses. 
 In the future, intermittent fasting studies should include longer implementation 
periods for subjects to partake in a larger, more diverse subject population, and a more 
controlled environment. Additionally, discovered data should be analyzed more in depth in 
order to correlate weight loss and secondary effects after following an intermittent fasting 
protocol. A better understanding of how intermittent fasting effects each of the risk factors of 
chronic disease needs to be analyzed.  
 But these health implications are relatively positive and reveal improvement of 
chronic disease risk factors. None of the 13 reviewed articles discussed an increase of health 
risk following an intermittent fasting protocol in either human or animal trials.   
With all things considered, it can be inferred that following an intermittent fasting 
protocol can positively improve the overall wellness of overweight or healthy humans and 
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decrease the risk of contracting a chronic illness and reduce the impact it has on one’s quality 
of life. 
Conclusion 
 In conclusion, all 13 of the reviewed studies point to an improvement in biological 
markers relating to cardiovascular stress, oxidative stress, and inflammation, all of which can 
lead to major chronic diseases. These biological markers were found to be improved after a 
short-term regimen of intermittent fasting; however, the studies were found to be more 
beneficial for animal subjects than human subjects. Human studies found a relatively positive 
interpretation of results, but, the effects on the reviewed risk markers were not consistent 
throughout and therefore were not conclusive on whether intermittent fasting could directly 
correlate to an improvement in chronic disease. Limitations of this review include the partial 
amount of studies reviewed, the short-term duration of the clinical studies, the contamination 
of weight loss and prior chronic disease diagnoses in subjects, and the inability to track 
subjects’ dietary choices during the intermittent fasting protocol. In the future, research 
should include long-term longitudinal studies of a greater subject population that investigate 
the ability for life-long intermittent fasting to prevent chronic disease. Clinically, it is 
concluded that intermittent fasting can be beneficial in the improvement of chronic disease 
risk markers, but more research needs to be conducted in order to produce conclusive results. 
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